Dermal tissue concentration is 4.2 higher with SubQ at 24 hours post-injection because the peptide diffuses laterally into target fibroblasts before entering systemic circulation
If we can't make a supplement that your body can actually use, we won't make it at all
The preclinical data on BPC-157 is genuinely interesting
What is encouraging, however, when thinking about the impact vaccination could have, is the apparent eradication of influenza A subtypes from the human population linked to cross-reactive immunity
Furthermore, no studies to date have reported pharmacokinetic parameters (e.g., absorption, bioavailability, tissue distribution), nor have they conducted long-term toxicity assessments or evaluated reproductive outcomes in vivo